Ingrid A. Beck

Ingrid A. Beck, T. Puthanakit, L. Frenkel, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection.

Ingrid A. Beck, M. Dybul, R. Dewar, 2004, The Journal of infectious diseases.

Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013–2014

Ingrid A. Beck, B. Chohan, B. Richardson, 2017, The Journal of infectious diseases.

Minority and majority pre-treatment HIV-1 drug resistance associated with failure of 1st-line NNRTI ART in Kenyan women.

Ingrid A. Beck, J. Kiarie, R. Coombs, 2019, AIDS.

Simplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide Ligation

Ingrid A. Beck, B. Lutz, J. Kiarie, 2016, PloS one.

Optimization of the Oligonucleotide Ligation Assay, a Rapid and Inexpensive Test for Detection of HIV-1 Drug Resistance Mutations, for Non-North American Variants

Ingrid A. Beck, Y. Shao, Sabelle Jallow, 2008, Journal of acquired immune deficiency syndromes.

OLA-Simple: A software-guided HIV-1 drug resistance test for low-resource laboratories

Parker S. Ruth, Justin D. Vrana, James J. Lai, 2019, EBioMedicine.

Detection of HIV-1 Drug Resistance in Women Following Administration of a Single Dose of Nevirapine: Comparison of Plasma RNA to Cellular DNA by Consensus Sequencing and by Oligonucleotide Ligation Assay

Ingrid A. Beck, L. Frenkel, Thor A Wagner, 2010, Journal of Clinical Microbiology.

Association of Virologic Failure and Nonnucleoside Reverse Transcriptase Inhibitor Resistance Found in Antiretroviral-Naive Children Infected With Human Immunodeficiency Virus and Given Efavirenz-Based Treatment.

Ingrid A. Beck, E. Capparelli, L. Frenkel, 2019, Journal of the Pediatric Infectious Diseases Society.

Blinded, Multicenter Comparison of Methods To Detect a Drug-Resistant Mutant of Human Immunodeficiency Virus Type 1 at Low Frequency

Ingrid A. Beck, K. Metzner, V. Johnson, 2006, Journal of Clinical Microbiology.

Persistence of HIV drug resistance among South African children given nevirapine to prevent mother-to-child-transmission

Ingrid A. Beck, L. Frenkel, T. Rossouw, 2017, AIDS (London).

Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort.

Parker S. Ruth, Ingrid A. Beck, S. Ávila-Ríos, 2020, AIDS.

Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component

Ingrid A. Beck, D. Moodley, L. Mofenson, 2021, Journal of acquired immune deficiency syndromes.

Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays

Parker S. Ruth, Justin D. Vrana, Ingrid A. Beck, 2021, EBioMedicine.

Inexpensive workflow for simultaneous monitoring of HIV viral load and detection of SARS-CoV-2 infection.

James J. Lai, Ingrid A. Beck, G. Gulati, 2021, medRxiv : the preprint server for health sciences.

Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge

Ingrid A. Beck, D. Montefiori, Shiu-Lok Hu, 2021, PloS one.

Diagnostic Accuracy of Dried Plasma Spot Specimens for HIV-1 Viral Load Testing: A Systematic Review and Meta-analysis

Ingrid A. Beck, Y. Fong, J. Nelson, 2021, Journal of acquired immune deficiency syndromes.

Low rate of SARS-CoV-2 incident infection identified by weekly screening PCR in a prospective year-long cohort study

Samantha J. Hardy, Ingrid A. Beck, Fred D. Mast, 2022, PloS one.

Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort

Ingrid A. Beck, J. Mullins, J. Herbeck, 2018, PLoS medicine.

Nevirapine-Resistant HIV-1 DNA in Breast Milk After Single-Dose Nevirapine With or Without Zidovudine for Prevention of Mother-to-Child Transmission.

Ingrid A. Beck, L. Frenkel, S. Gloyd, 2012, Journal of the Pediatric Infectious Diseases Society.

Comparison of Matrix-Based and Filter Paper-Based Systems for Transport of Plasma for HIV-1 RNA Quantification and Amplicon Preparation for Genotyping

Ingrid A. Beck, L. Frenkel, G. Pepper, 2016, Journal of Clinical Microbiology.

Low concentrations of HIV-1 DNA at birth delays diagnosis, complicating identification of infants for antiretroviral therapy to potentially prevent the establishment of viral reservoirs.

Ingrid A. Beck, C. Mitchell, L. Frenkel, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.

Ingrid A. Beck, P. Krogstad, S. Nachman, 2012, AIDS research and human retroviruses.

Massively Parallel Sequencing Drug-Resistant Mutants by Use of Immunodeficiency Virus Type 1 Assay for Quantification of Human Validation of an Oligonucleotide Ligation

Roger E Bumgarner, Ingrid A. Beck, J. Mullins, 2014 .

Increasing HIV-1 pretreatment drug resistance among antiretroviral-naïve adults initiating treatment between 2006 and 2014 in Nairobi, Kenya

Ingrid A. Beck, B. Chohan, J. Kiarie, 2016, AIDS.